Download PDF
Thorac Cardiovasc Surg 2005; 53(6): 358-364
DOI: 10.1055/s-2005-865758
Original Thoracic

© Georg Thieme Verlag KG Stuttgart · New York

Characteristic Differences between Patients Who Have Undergone Surgical Treatment for Lung Metastasis or Hepatic Metastasis From Colorectal Cancer

A. Iwasaki1 , T. Shirakusa1 , Y. Yamashita1 , T. Noritomi1 , T. Maekawa1 , T. Hamada1
  • 1Second Department of Surgery, School of Medicine, Fukuoka University, Japan
Further Information

Publication History

Received April 6, 2005

Publication Date:
28 November 2005 (online)

    Permissions and Reprints All articles of this category

Abstract

Objective: The characteristic differences between patients with lung or liver metastases from colorectal carcinoma (CRC) have not yet been clarified. A small group of these patients demonstrate a better prognosis, and the selection criteria for resection of liver and/or lung metastasis are not well defined. It is important to compare and analyze the most common metastatic sites, which include liver metastases and lung metastases. The objective of this study was to compare the characteristics of the two groups in order to identify patients who benefitted from surgical resection of CRC. Methods: We retrospectively reviewed the medical charts of 80 patients who had undergone resection for liver or lung metastasis from CRC in Fukuoka University Hospital between June 1991 and December 2004. These patients were grouped according to surgical therapy received for the metastases, and separated into two groups, as follows: LUM, lung metastases resection; LIM, liver metastases resection. We evaluated these groups for a set of several factors. Results: The characteristic factors between the two groups (LUM vs. LIM) demonstrated significant differences according to histological differentiation, venous invasion, and lymphatic permeation. There was a statistical difference in the disease-free interval (DFI) between the two groups (947.06 ± 840.39 days in LUM vs. 246.03 ± 229.26 days in LIM). Although serum CEA levels at resection of metastasis showed significant differences between the groups (LUM, 13.25 ± 31.55 ng/ml; LIM, 55.21 ± 99.52 ng/ml), the primary serum CEA levels were not significantly different. Overall survival rates at 5 years were 37.0 % for LUM and 42.8 % for LIM. There was no significant difference in the survival rate of the LUM vs. the LIM group after resection of metastasis. The Cox proportional hazards regression model was used to determine serum CEA status at the time of the metastases and showed a significant difference indicating poor prognosis for patients with LUM, but the results were not significant for LIM cases. Conclusions: Candidates for surgical treatment for lung or liver metastases from CRC may be an acceptable for the same valuable approach, even if characteristic differences were observed in each group.

Key words

Metastatic lung tumor - metastatic liver tumor - colorectal cancer (CRC) - prognosis - disease-free interval (DFI)

References

  • 1 Welch J P, Donaldson G A. Detection and treatment of recurrent cancer of the colon and rectum.  Am J Surg. 1973;  135 505-511
    PubMedGoogle Scholar
  • 2 Glandiuk S, Wieand H S, Moertel C G, Cha S S, Fitzgibbons R J, Pemberton J A. Pattern of recurrence after curative resection of carcinoma of the colon and rectum.  Surg Gynecol Obstet. 1992;  174 27-32
    PubMedGoogle Scholar
  • 3 Jatzko G R, Lisborg P H, Stettner H M, Klimpfinger M H. Hepatic resection for metastases from colorectal carcinoma: a survival analysis.  Eur J Cancer. 1995;  31 41-46
    CrossrefPubMedGoogle Scholar
  • 4 Rena O, Casadio C, Viano F, Cristofori R, Ruffini E, Filosso P L, Maggi G. Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. Twenty-year experience.  Eur J Cardiothorac Surg. 2002;  21 906-912
    CrossrefPubMedGoogle Scholar
  • 5 Headrick J R, Miller D L, Nagorney D M, Allen M S, Deschamps C, Trastek V F, Pairolero P C. Surgical treatment of hepatic and pulmonary metastases from colon cancer.  Ann Thorac Surg. 2001;  71 975-979
    CrossrefPubMedGoogle Scholar
  • 6 Landreneau R J, Giacomo T D, Mack M J, Hazelrigg S R, Ferson P F, Keenan R J, Luketich J D, Yim A P, Coloni G F. Therapeutic video-assisted thoracoscopic surgical resection of colorectal pulmonary metastases.  Eur J Cardiothorac Surg. 2000;  18 671-677
    CrossrefPubMedGoogle Scholar
  • 7 Tamura M, Oda M, Tsunezuka Y, Matsumoto I, Kawakami K, Watanabe G. Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as prognostic factor.  J Thorac Cardiovasc Surg. 2004;  128 517-522
    CrossrefPubMedGoogle Scholar
  • 8 Shiono S, Ishii G, Nagai K, Yoshida J, Nishimura M, Murata Y, Tsuta K, Nishiwaki Y, Kodama T, Ochiai A. Histopathologic prognostic factors in resected colorectal lung metastases.  Ann Thorac Surg. 2005;  79 278-283
    CrossrefPubMedGoogle Scholar
  • 9 Shirakusa T, Tsutsui M, Notonaga R, Ando K, Kusano T. Resection of metastatic lung tumor: the evaluation of histologic appearance in the lung.  The American Surgeon. 1988;  54 655-658
    PubMedGoogle Scholar
  • 10 Ruers T J, Langenhoff B S, Neeleman N, Jager G J, Strijk S, Wobbes T, Corstens F H, Oyen W J. Value of positron emission tomography with (F-18) fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.  J Clin Oncol. 2002;  20 388-395
    CrossrefPubMedGoogle Scholar
  • 11 Stessels F, Van den Eynden G, Van der Auwera I, Salgado R, Van den Heuvel E, Harris A L, Jackson D G, Colpaert C G, van Marck E A, Dirix L Y, Vermeulen P B. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia.  Br J Cancer. 2004;  90 1429-1436
    CrossrefPubMedGoogle Scholar
  • 12 Zink S, Kayser G, Gabius H J, Kayser K. Survival, disease-free interval, and associated tumor features in patients with colon/rectal carcinomas and their resected intra-pulmonary metastases.  Eur J Cardiothorac Surg. 2001;  19 908-913
    CrossrefPubMedGoogle Scholar
  • 13 Sakamoto T, Tsubota N, Iwanaga K, Yuki T, Matsuoka H, Yoshimura M. Pulmonary resection for metastases from colorectal cancer.  Chest. 2001;  119 1069-1072
    CrossrefPubMedGoogle Scholar
  • 14 Sato T, Konishi K, Yabushita K, Nojima N, Kimura H, Maeda K, Tsuji M, Miwa A. The time interval between primary colorectal carcinoma resection to occurrence of liver metastases is the most important factor for hepatic resection. Analysis of total course following primary resection of colorectal cancer.  Int Surg. 1998;  83 340-342
    PubMedGoogle Scholar
  • 15 Finlay I G, Meek D R, Gray H W. Incidence and detection of occult hepatic metastases in colorectal carcinoma.  Br Med J. 1982;  284 803-805
    PubMedGoogle Scholar
  • 16 O'Reilly M S, Boehm T, Shing Y, Fukai N, Vasios G, Lane W S, Flynn E, Birkhead J R, Olsen B R, Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.  Cell. 1997;  88 277-285
    CrossrefPubMedGoogle Scholar
  • 17 Hara Y, Ogata Y, Shirouzu K. Early tumor growth in metastatic organs influenced by the microenvironment is an important factor which provides organ specificity of colon cancer metastasis.  J Exp Clin Cancer Res. 2000;  19 497-504
    PubMedGoogle Scholar
  • 18 Peeters C F, Westphal J R, de Waal R M, Ruiter D J, Wobbes T, Ruers T J. Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients.  Int J Cancer. 2004;  112 554-559
    CrossrefPubMedGoogle Scholar
  • 19 Higashiyama M, Kodama K, Higaki N, Takami K, Murata K, Kameyama M, Yokouchi H. Surgery for pulmonary metastases from colorectal cancer: the importance of prethoracotomy serum carcinoembryonic antigen as an indicator of prognosis.  Jpn J Thorac Cardiovasc Surg. 2003;  51 289-296
    CrossrefPubMedGoogle Scholar
  • 20 Topal B, Kaufman L, Aerts R, Penninckx F. Patterns of failure following curative resection of colorectal liver metastases.  Eur J Surg Oncol. 2003;  29 248-253
    CrossrefPubMedGoogle Scholar
  • 21 Jessup J M, Petrick A T, Toth C A, Ford R, Meterissian S, O'Hara C J, Steele Jr G, Thomas P. Carcinoembryonic antigen: enhancement of liver colonisation through resection of human colorectal carcinoma cells.  Br J Cancer. 1993;  67 464-470
    PubMedGoogle Scholar
  • 22 Koshiji M, Ogura E, Takada H, Kawanishi H, Ikehara S, Hioki K. Clinicopathologic and immunohistochemical analyses in lung metastasis of colorectal carcinoma.  Oncol Rep. 1998;  5 811-815
    PubMedGoogle Scholar
  • 23 Ueda K, Iwahashi M, Nakamori M, Nakamura M, Matsuura I, Ojima T, Yamaue H. Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer.  Surgery. 2003;  133 309-317
    CrossrefPubMedGoogle Scholar
  • 24 Sawa T, Yoshida T, Ikoma T, Toyoda M, Ohno Y, Fujiwara H. Evaluation of the increasing serum lactate dehydrogenase caused by recombinant human granulocyte-colony stimulating factor.  Gan To Kagaku Ryoho. 2003;  30 51-58
    PubMedGoogle Scholar
  • 25 Patel N A, Keenan R J, Medich D S, Woo Y, Celebrezze J, Santucci T, Maley R, Landreneau R L, Roh M S. The presence of colorectal hepatic metastases does not preclude pulmonary metastasectomy.  Am Surg. 2003;  69 1047-1053
    PubMedGoogle Scholar

Dr. Akinori Iwasaki

Second Department of Surgery
School of Medicine
Fukuoka University

45-1, 7-chome Nanakuma, Jonan-ku,

Fukuoka 814-0180

Japan

Phone: + 81-92-801-1011

Fax: + 81-92-861-8271

Email: iwasaki@fukuoka-u.ac.jp

      >